Krystal Biotech Announces Home Dosing in B-VEC Open Label Extension Study
Go back to Krystal Biotech Announces Home Dosing in B-VEC Open Label Extension Study| (NASDAQ: KRYS) | Delayed: 363.44 -2.37 (0.65%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $365.81 | 52 Week High | $ | |||
| Open | $361.94 | 52 Week Low | $ | |||
| Day High | $367.79 | P/E | N/A | |||
| Day Low | $353.49 | EPS | $ | |||
| Volume | 378,812 | |||||

